AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. PHLT
  4. [Form 4] Performant Healthcare, Inc. Insider Trading Activity

[Form 4] Performant Healthcare, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Rohit Ramchandani, Chief Financial Officer of Performant Healthcare, Inc. (PHLT), reported transactions dated 08/11/2025 reflecting restricted stock unit activity and related share dispositions to satisfy tax withholding. Two sets of restricted stock units converted to common shares: 23,162 (grant dated 08/08/2022) and 16,267 (grant dated 08/05/2024), each awarded at no cost and vesting in four equal annual installments subject to continued service and change-in-control provisions.

To cover tax liabilities on the vesting, the reporting person surrendered 11,531 and 8,098 shares, disposed at $7.63 per share. The filing shows a reported common stock beneficial ownership level of 253,315 shares following these transactions and 48,792 restricted stock units in aggregate.

Rohit Ramchandani, Direttore finanziario di Performant Healthcare, Inc. (PHLT), ha dichiarato operazioni in data 08/11/2025 relative ad attivit脿 di unit脿 azionarie vincolate (RSU) e alla cessione di azioni per soddisfare le ritenute fiscali. Due tranche di RSU sono state convertite in azioni ordinarie: 23,162 (concessione del 08/08/2022) e 16,267 (concessione del 08/05/2024), entrambe assegnate a titolo gratuito e soggette a maturazione in quattro rate annuali uguali, subordinate alla prosecuzione del servizio e a clausole in caso di cambiamento di controllo.

Per coprire le imposte dovute al vesting, il dichiarante ha ceduto 11,531 e 8,098 azioni, disposte a $7.63 per azione. La segnalazione indica una partecipazione in azioni ordinarie pari a 253,315 azioni dopo tali operazioni e un totale di 48,792 RSU.

Rohit Ramchandani, Director financiero de Performant Healthcare, Inc. (PHLT), inform贸 operaciones con fecha 08/11/2025 relativas a unidades de acciones restringidas (RSU) y a la disposici贸n de acciones para cubrir retenciones fiscales. Dos series de RSU se convirtieron en acciones ordinarias: 23,162 (concesi贸n del 08/08/2022) y 16,267 (concesi贸n del 08/05/2024), ambas otorgadas sin costo y sujetas a consolidaci贸n en cuatro cuotas anuales iguales, condicionadas a la continuidad del servicio y a disposiciones por cambio de control.

Para cubrir las obligaciones fiscales por el vesting, la persona informante entreg贸 11,531 y 8,098 acciones, dispuestas a $7.63 por acci贸n. La presentaci贸n muestra una tenencia efectiva de acciones ordinarias de 253,315 acciones tras estas operaciones y un total agregado de 48,792 RSU.

Rohit Ramchandani, Performant Healthcare, Inc. (PHLT)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO)電� 08/11/2025鞛� 瓯半灅氤搓碃鞐愳劀 鞝滍暅欤检嫕雼渼(RSU) 頇滊彊 氚� 靹戈笀 鞗愳矞歆曥垬毳� 於╇嫻頃橁赴 鞙勴暅 欤检嫕 觳橂秳鞚� 氤搓碃頄堨姷雼堧嫟. 霊� 瓯挫潣 RSU臧� 氤错喌欤茧 鞝勴櫂霅橃棃鞀惦媹雼�: 23,162 (攵赌鞐澕 08/08/2022) 氚� 16,267 (攵赌鞐澕 08/05/2024), 氇憪 氍挫儊鞙茧 攵�鞐悩鞐堨溂氅� 瓿勳啀 攴茧鞕� 瓴届榿甓� 氤�瓴� 臁绊暛鞚� 臁瓣贝鞙茧 4雲� 霃欖晥 毵る厔 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺惄雼堧嫟.

氩犾姢韺呾棎 霐半ジ 靹戈笀 攵�雼挫潉 於╇嫻頃橁赴 鞙勴暣 氤搓碃鞛愲姅 11,531欤检檧 8,098欤茧ゼ 觳橂秳頄堨溂氅�, 觳橂秳 雼皜電� 欤茧嫻 $7.63鞓�鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 鞚措摛 瓯半灅 鞚错泟 氤搓碃霅� 氤错喌欤� 鞁れ唽鞙犼皜 253,315欤检澊瓿� 鞝勳泊 RSU電� 48,792瓯挫溂搿� 響滉赴霅橃柎 鞛堨姷雼堧嫟.

Rohit Ramchandani, directeur financier de Performant Healthcare, Inc. (PHLT), a d茅clar茅 des transactions dat茅es du 08/11/2025 portant sur des unit茅s d'actions restreintes (RSU) et des cessions d'actions destin茅es 脿 couvrir les retenues fiscales. Deux s茅ries de RSU ont 茅t茅 converties en actions ordinaires : 23,162 (attribution en date du 08/08/2022) et 16,267 (attribution en date du 08/05/2024), toutes deux attribu茅es 脿 titre gratuit et acquises en quatre versements annuels 茅gaux, sous r茅serve de la poursuite du service et de dispositions en cas de changement de contr么le.

Pour couvrir les imp么ts li茅s au vesting, la personne d茅clar茅e a c茅d茅 11,531 et 8,098 actions, vendues 脿 $7.63 l'action. Le dossier indique une participation en actions ordinaires de 253,315 actions apr猫s ces op茅rations et un total de 48,792 RSU.

Rohit Ramchandani, Chief Financial Officer von Performant Healthcare, Inc. (PHLT), meldete Transaktionen vom 08/11/2025, die Aktivit盲ten mit Restricted Stock Units (RSU) und damit verbundene Aktienver盲u脽erungen zur Begleichung von Steuerabz眉gen betreffen. Zwei RSU-Tranchen wurden in Stammaktien umgewandelt: 23,162 (Gew盲hrung am 08/08/2022) und 16,267 (Gew盲hrung am 08/05/2024), jeweils unentgeltlich gew盲hrt und 眉ber vier gleiche j盲hrliche Raten gew盲hrt, vorbehaltlich fortgesetzter Dienstzeit und Change-in-Control-Bestimmungen.

Zur Deckung der Steuerverpflichtungen aus dem Vesting gab die meldende Person 11,531 und 8,098 Aktien ab, ver盲u脽ert zu $7.63 je Aktie. Die Meldung weist nach diesen Transaktionen eine gemeldete Beteiligung an Stammaktien von 253,315 Aktien sowie insgesamt 48,792 RSU aus.

Positive
  • Receipt of RSUs at no cost: Aggregated 48,792 restricted stock units awarded and reflected in the filing, representing potential future equity alignment with management.
  • Continued ownership: Reporting person retains a reported 253,315 shares after the transactions, indicating sustained insider ownership.
Negative
  • Share disposition for tax withholding: A total of 19,629 shares were surrendered/ disposed (11,531 and 8,098) at $7.63 per share to satisfy tax liabilities related to vesting.

Insights

TL;DR: Routine executive equity vesting with tax-surrender; no clear material change to ownership stake from these actions.

The Form 4 documents the vesting of RSUs and simultaneous surrender of a portion of the resulting shares to satisfy tax withholding. Total vested amounts were 23,162 and 16,267 RSUs, with 19,629 shares surrendered at $7.63 per share. The reporting person continues to hold a substantial position鈥攔eported at 253,315 shares鈥攚hile maintaining 48,792 RSUs outstanding. These actions are typical compensation-related transactions and do not, by themselves, indicate a change in company fundamentals.

TL;DR: Compensation vesting and tax withholding handled via share surrender; governance terms specify time-based vesting and change-in-control acceleration.

The filing explicitly describes time-based restricted stock unit awards granted on 08/08/2022 and 08/05/2024 that vest in four equal installments on the anniversaries, subject to continued service and acceleration on change in control. The use of share surrender to cover taxes is a common administrative mechanism consistent with typical equity compensation plans. No departures, loans, or unusual derivative exercises are disclosed.

Rohit Ramchandani, Direttore finanziario di Performant Healthcare, Inc. (PHLT), ha dichiarato operazioni in data 08/11/2025 relative ad attivit脿 di unit脿 azionarie vincolate (RSU) e alla cessione di azioni per soddisfare le ritenute fiscali. Due tranche di RSU sono state convertite in azioni ordinarie: 23,162 (concessione del 08/08/2022) e 16,267 (concessione del 08/05/2024), entrambe assegnate a titolo gratuito e soggette a maturazione in quattro rate annuali uguali, subordinate alla prosecuzione del servizio e a clausole in caso di cambiamento di controllo.

Per coprire le imposte dovute al vesting, il dichiarante ha ceduto 11,531 e 8,098 azioni, disposte a $7.63 per azione. La segnalazione indica una partecipazione in azioni ordinarie pari a 253,315 azioni dopo tali operazioni e un totale di 48,792 RSU.

Rohit Ramchandani, Director financiero de Performant Healthcare, Inc. (PHLT), inform贸 operaciones con fecha 08/11/2025 relativas a unidades de acciones restringidas (RSU) y a la disposici贸n de acciones para cubrir retenciones fiscales. Dos series de RSU se convirtieron en acciones ordinarias: 23,162 (concesi贸n del 08/08/2022) y 16,267 (concesi贸n del 08/05/2024), ambas otorgadas sin costo y sujetas a consolidaci贸n en cuatro cuotas anuales iguales, condicionadas a la continuidad del servicio y a disposiciones por cambio de control.

Para cubrir las obligaciones fiscales por el vesting, la persona informante entreg贸 11,531 y 8,098 acciones, dispuestas a $7.63 por acci贸n. La presentaci贸n muestra una tenencia efectiva de acciones ordinarias de 253,315 acciones tras estas operaciones y un total agregado de 48,792 RSU.

Rohit Ramchandani, Performant Healthcare, Inc. (PHLT)鞚� 斓滉碃鞛毂呾瀯鞛�(CFO)電� 08/11/2025鞛� 瓯半灅氤搓碃鞐愳劀 鞝滍暅欤检嫕雼渼(RSU) 頇滊彊 氚� 靹戈笀 鞗愳矞歆曥垬毳� 於╇嫻頃橁赴 鞙勴暅 欤检嫕 觳橂秳鞚� 氤搓碃頄堨姷雼堧嫟. 霊� 瓯挫潣 RSU臧� 氤错喌欤茧 鞝勴櫂霅橃棃鞀惦媹雼�: 23,162 (攵赌鞐澕 08/08/2022) 氚� 16,267 (攵赌鞐澕 08/05/2024), 氇憪 氍挫儊鞙茧 攵�鞐悩鞐堨溂氅� 瓿勳啀 攴茧鞕� 瓴届榿甓� 氤�瓴� 臁绊暛鞚� 臁瓣贝鞙茧 4雲� 霃欖晥 毵る厔 霃欖澕頃� 牍勳湪搿� 氩犾姢韺呺惄雼堧嫟.

氩犾姢韺呾棎 霐半ジ 靹戈笀 攵�雼挫潉 於╇嫻頃橁赴 鞙勴暣 氤搓碃鞛愲姅 11,531欤检檧 8,098欤茧ゼ 觳橂秳頄堨溂氅�, 觳橂秳 雼皜電� 欤茧嫻 $7.63鞓�鞀惦媹雼�. 鞝滌稖靹滊鞐愲姅 鞚措摛 瓯半灅 鞚错泟 氤搓碃霅� 氤错喌欤� 鞁れ唽鞙犼皜 253,315欤检澊瓿� 鞝勳泊 RSU電� 48,792瓯挫溂搿� 響滉赴霅橃柎 鞛堨姷雼堧嫟.

Rohit Ramchandani, directeur financier de Performant Healthcare, Inc. (PHLT), a d茅clar茅 des transactions dat茅es du 08/11/2025 portant sur des unit茅s d'actions restreintes (RSU) et des cessions d'actions destin茅es 脿 couvrir les retenues fiscales. Deux s茅ries de RSU ont 茅t茅 converties en actions ordinaires : 23,162 (attribution en date du 08/08/2022) et 16,267 (attribution en date du 08/05/2024), toutes deux attribu茅es 脿 titre gratuit et acquises en quatre versements annuels 茅gaux, sous r茅serve de la poursuite du service et de dispositions en cas de changement de contr么le.

Pour couvrir les imp么ts li茅s au vesting, la personne d茅clar茅e a c茅d茅 11,531 et 8,098 actions, vendues 脿 $7.63 l'action. Le dossier indique une participation en actions ordinaires de 253,315 actions apr猫s ces op茅rations et un total de 48,792 RSU.

Rohit Ramchandani, Chief Financial Officer von Performant Healthcare, Inc. (PHLT), meldete Transaktionen vom 08/11/2025, die Aktivit盲ten mit Restricted Stock Units (RSU) und damit verbundene Aktienver盲u脽erungen zur Begleichung von Steuerabz眉gen betreffen. Zwei RSU-Tranchen wurden in Stammaktien umgewandelt: 23,162 (Gew盲hrung am 08/08/2022) und 16,267 (Gew盲hrung am 08/05/2024), jeweils unentgeltlich gew盲hrt und 眉ber vier gleiche j盲hrliche Raten gew盲hrt, vorbehaltlich fortgesetzter Dienstzeit und Change-in-Control-Bestimmungen.

Zur Deckung der Steuerverpflichtungen aus dem Vesting gab die meldende Person 11,531 und 8,098 Aktien ab, ver盲u脽ert zu $7.63 je Aktie. Die Meldung weist nach diesen Transaktionen eine gemeldete Beteiligung an Stammaktien von 253,315 Aktien sowie insgesamt 48,792 RSU aus.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ramchandani Rohit
(Last) (First) (Middle)
900 SOUTH PINE ISLAND ROAD
SUITE 150
(Street)
PLANTATION FL 33324
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Performant Healthcare Inc [ PHLT ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 per share 08/11/2025 M 23,162 A $0 256,677 D
Common Stock, par value $0.0001 per share 08/11/2025 F 11,531(1) D $7.63 245,146 D
Common Stock, par value $0.0001 per share 08/11/2025 M 16,267 A $0 261,413 D
Common Stock, par value $0.0001 per share 08/11/2025 F 8,098(1) D $7.63 253,315 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $0(2) 08/11/2025 M 23,162 (3) (3) Common Stock 23,162 $0(2) 23,162 D
Restricted Stock Units $0(2) 08/11/2025 M 16,267 (4) (4) Common Stock 16,267 $0(2) 48,792 D
Explanation of Responses:
1. Shares surrendered to pay tax liability due on vesting of Restricted Stock Units
2. Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to Reporting Person.
3. Restricted Stock Unit award was granted on August 8, 2022 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.
4. Restricted Stock Unit Award was granted on August 5, 2024 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.
Remarks:
/s/ Rohit Ramchandani 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

FAQ

What transactions did PHLT CFO Rohit Ramchandani report on Form 4?

The Form 4 reports the vesting/conversion of RSUs into 23,162 and 16,267 common shares and the surrender/disposition of 11,531 and 8,098 shares to cover tax withholding.

How many shares were sold and at what price in the reported PHLT transactions?

The filing shows dispositions of 11,531 and 8,098 shares at a price of $7.63 per share, used to satisfy tax liabilities.

What is the reporting person鈥檚 beneficial ownership after these transactions?

Following the reported transactions, the filing shows a beneficial ownership level of 253,315 shares of PHLT common stock.

How many restricted stock units does the CFO have and what are the grant dates?

The filing references RSU awards of 23,162 (grant date 08/08/2022) and 16,267 (grant date 08/05/2024), with 48,792 RSUs reported in total; each RSU is a contingent right to one share awarded at no cost.

Do the RSUs have vesting conditions?

Yes; each RSU vests in four equal installments on the first trading-window day after each anniversary of the grant date, conditioned on continuous service and subject to acceleration under the reporting person鈥檚 Change in Control and Severance Agreement.
Stock PHLT logo
Performant Finl Corp

NASDAQ:PHLT

PHLT Rankings

#3115 Ranked by Market Cap
N/A Ranked by Dividends

PHLT Latest News

Aug 1, 2025
Performant Healthcare, Inc. Announces Preliminary Financial Results for Second Quarter 2025
Aug 1, 2025
Performant Healthcare, Inc. to Be Acquired by Machinify
Jul 24, 2025
Performant Healthcare, Inc. to Report Second Quarter 2025 Earnings on August 5, 2025
May 14, 2025
Performant to Participate in B Riley Securities鈥� 25th Annual Institutional Investor Conference
May 8, 2025
Performant Healthcare, Inc. Announces Financial Results for First Quarter 2025

PHLT Latest SEC Filings

Aug 28, 2025
[PREM14A] Performant Healthcare, Inc. Preliminary Merger Proxy Statement
Aug 21, 2025
[SCHEDULE 13G] Performant Healthcare, Inc. SEC Filing
Aug 20, 2025
[Form 4] Performant Healthcare, Inc. Insider Trading Activity
Aug 20, 2025
[Form 4] Performant Healthcare, Inc. Insider Trading Activity
Aug 15, 2025
[Form 4] Performant Healthcare, Inc. Insider Trading Activity

PHLT Stock Data

602.75M
69.74M
7.59%
92.38%
1.11%
Health Information Services
Services-miscellaneous Business Services
United States
PLANTATION